IL10 and cystic fibrosis: Moreover, a clinical trial (phase II NTC 02649751) was investigating the function of roscovitine in the chronic inflammatory lung disease cystic fibrosis by monitoring pro- (TNF-α) and anti-inflammatory (IL-10) parameters, among others.